Development of a Highly Selective c-Src Kinase Inhibitor

被引:117
作者
Brandvold, Kristoffer R. [1 ]
Steffey, Michael E. [1 ]
Fox, Christel C. [1 ]
Soellner, Matthew B. [1 ,2 ]
机构
[1] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
CANCER; ABL; RESISTANCE; DISCOVERY; IMATINIB; POTENT; LCK;
D O I
10.1021/cb300172e
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Generating highly selective probes to interrogate protein kinase function in biological studies remains a challenge, and new strategies are required. Herein, we describe the development of the first highly selective and cell-permeable inhibitor of c-Src, a key signaling kinase in cancer. Our strategy involves extension of traditional inhibitor design by appending functionality proposed to interact with the phosphate-binding loop of c-Src. Using our selective inhibitor, we demonstrate that selective inhibition is significantly more efficacious than pan-kinase inhibition in slowing the growth of cancer cells. We also show that inhibition of c-Abl kinase, an off-target of most c-Src inhibitors, promotes oncogenic cell growth.
引用
收藏
页码:1393 / 1398
页数:6
相关论文
共 33 条
[1]
Adrian F. J., 2006, NAT CHEM BIOL, V2, P95
[2]
The Cain and Abl of Epithelial-Mesenchymal Transition and Transforming Growth Factor-β in Mammary Epithelial Cells [J].
Allington, Tressa M. ;
Schiemann, William P. .
CELLS TISSUES ORGANS, 2011, 193 (1-2) :98-113
[3]
Activated Abl kinase inhibits oncogenic transforming growth factor-β signaling and tumorigenesis in mammary tumors [J].
Allington, Tressa M. ;
Galliher-Beckley, Amy J. ;
Schiemann, William P. .
FASEB JOURNAL, 2009, 23 (12) :4231-4243
[4]
The selectivity of protein kinase inhibitors: a further update [J].
Bain, Jenny ;
Plater, Lorna ;
Elliott, Matt ;
Shpiro, Natalia ;
Hastie, C. James ;
Mclauchlan, Hilary ;
Klevernic, Iva ;
Arthur, J. Simon C. ;
Alessi, Dario R. ;
Cohen, Philip .
BIOCHEMICAL JOURNAL, 2007, 408 :297-315
[5]
A chemical switch for inhibitor-sensitive alleles of any protein kinase [J].
Bishop, AC ;
Ubersax, JA ;
Petsch, DT ;
Matheos, DP ;
Gray, NS ;
Blethrow, J ;
Shimizu, E ;
Tsien, JZ ;
Schultz, PG ;
Rose, MD ;
Wood, JL ;
Morgan, DO ;
Shokat, KM .
NATURE, 2000, 407 (6802) :395-401
[6]
Comprehensive analysis of kinase inhibitor selectivity [J].
Davis, Mindy I. ;
Hunt, Jeremy P. ;
Herrgard, Sanna ;
Ciceri, Pietro ;
Wodicka, Lisa M. ;
Pallares, Gabriel ;
Hocker, Michael ;
Treiber, Daniel K. ;
Zarrinkar, Patrick P. .
NATURE BIOTECHNOLOGY, 2011, 29 (11) :1046-U124
[7]
A small molecule-kinase interaction map for clinical kinase inhibitors [J].
Fabian, MA ;
Biggs, WH ;
Treiber, DK ;
Atteridge, CE ;
Azimioara, MD ;
Benedetti, MG ;
Carter, TA ;
Ciceri, P ;
Edeen, PT ;
Floyd, M ;
Ford, JM ;
Galvin, M ;
Gerlach, JL ;
Grotzfeld, RM ;
Herrgard, S ;
Insko, DE ;
Insko, MA ;
Lai, AG ;
Lélias, JM ;
Mehta, SA ;
Milanov, ZV ;
Velasco, AM ;
Wodicka, LM ;
Patel, HK ;
Zarrinkar, PP ;
Lockhart, DJ .
NATURE BIOTECHNOLOGY, 2005, 23 (03) :329-336
[8]
Georghiou G, 2012, NAT CHEM BIOL, V8, P366, DOI [10.1038/NCHEMBIO.792, 10.1038/nchembio.792]
[9]
Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor - Study of Lck- and FynT-dependent T cell activation [J].
Hanke, JH ;
Gardner, JP ;
Dow, RL ;
Changelian, PS ;
Brissette, WH ;
Weringer, EJ ;
Pollok, K ;
Connelly, PA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (02) :695-701
[10]
c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function [J].
Ishizawar, R. C. ;
Miyake, T. ;
Parsons, S. J. .
ONCOGENE, 2007, 26 (24) :3503-3510